PLOS GENET 润色咨询

PLoS Genetics

出版年份:2005 年文章数:11195 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=978599, encodeId=c9b29e8599e1, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:生物信息;遗传<br>经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd95538628, createdName=无名氏大神, createdTime=Thu Jul 01 12:28:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115163, encodeId=785521151634a, content=这个期刊要求提交WB、RT-PCR等实验的原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8798538309, createdName=ms8000001983091391, createdTime=Fri Feb 17 22:49:05 CST 2023, time=2023-02-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1004198, encodeId=eaa410041988e, content=偏重的研究方向: 昆虫学 ; 遗传学 <br>经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7d5455041, createdName=ms9000000745584421, createdTime=Sat Jul 31 11:05:31 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199422, encodeId=234d119942250, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:遗传育种;生信分析<br>经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Fri Mar 04 16:26:29 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199424, encodeId=0a23119942413, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=ae0510446253' target=_blank style='color:#2F92EE;'>#周舟#</a>我的到现在还没有审核通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=104462, encryptionId=ae0510446253, topicName=周舟)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Fri Mar 04 16:31:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097241, encodeId=94dd109e2414e, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097242, encodeId=5329109e24253, content=对于审稿人好的意见也要回复么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186528, encodeId=dc04118652824, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:林学<br>经验分享:非常好的一个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Thu Jan 20 18:20:59 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575607, encodeId=b8ee5e5607a0, content=这杂志临床回顾性研究要吗<span class="quote">215245994_27814198 2018-10-18 16:18:00 发表:<br>刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的</span>, beContent=215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562132, encodeId=e1b356213248, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6332115095, createdName=215245994_27814198, createdTime=Thu Oct 18 16:18:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]
    2021-07-01 无名氏大神

    审稿速度:12.0 | 投稿命中率:5.0
    偏重的研究方向:生物信息;遗传
    经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=978599, encodeId=c9b29e8599e1, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:生物信息;遗传<br>经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd95538628, createdName=无名氏大神, createdTime=Thu Jul 01 12:28:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115163, encodeId=785521151634a, content=这个期刊要求提交WB、RT-PCR等实验的原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8798538309, createdName=ms8000001983091391, createdTime=Fri Feb 17 22:49:05 CST 2023, time=2023-02-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1004198, encodeId=eaa410041988e, content=偏重的研究方向: 昆虫学 ; 遗传学 <br>经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7d5455041, createdName=ms9000000745584421, createdTime=Sat Jul 31 11:05:31 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199422, encodeId=234d119942250, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:遗传育种;生信分析<br>经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Fri Mar 04 16:26:29 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199424, encodeId=0a23119942413, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=ae0510446253' target=_blank style='color:#2F92EE;'>#周舟#</a>我的到现在还没有审核通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=104462, encryptionId=ae0510446253, topicName=周舟)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Fri Mar 04 16:31:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097241, encodeId=94dd109e2414e, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097242, encodeId=5329109e24253, content=对于审稿人好的意见也要回复么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186528, encodeId=dc04118652824, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:林学<br>经验分享:非常好的一个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Thu Jan 20 18:20:59 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575607, encodeId=b8ee5e5607a0, content=这杂志临床回顾性研究要吗<span class="quote">215245994_27814198 2018-10-18 16:18:00 发表:<br>刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的</span>, beContent=215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562132, encodeId=e1b356213248, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6332115095, createdName=215245994_27814198, createdTime=Thu Oct 18 16:18:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]
    2023-02-17 ms8000001983091391 来自重庆

    这个期刊要求提交WB、RT-PCR等实验的原始数据吗?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=978599, encodeId=c9b29e8599e1, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:生物信息;遗传<br>经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd95538628, createdName=无名氏大神, createdTime=Thu Jul 01 12:28:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115163, encodeId=785521151634a, content=这个期刊要求提交WB、RT-PCR等实验的原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8798538309, createdName=ms8000001983091391, createdTime=Fri Feb 17 22:49:05 CST 2023, time=2023-02-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1004198, encodeId=eaa410041988e, content=偏重的研究方向: 昆虫学 ; 遗传学 <br>经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7d5455041, createdName=ms9000000745584421, createdTime=Sat Jul 31 11:05:31 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199422, encodeId=234d119942250, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:遗传育种;生信分析<br>经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Fri Mar 04 16:26:29 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199424, encodeId=0a23119942413, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=ae0510446253' target=_blank style='color:#2F92EE;'>#周舟#</a>我的到现在还没有审核通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=104462, encryptionId=ae0510446253, topicName=周舟)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Fri Mar 04 16:31:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097241, encodeId=94dd109e2414e, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097242, encodeId=5329109e24253, content=对于审稿人好的意见也要回复么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186528, encodeId=dc04118652824, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:林学<br>经验分享:非常好的一个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Thu Jan 20 18:20:59 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575607, encodeId=b8ee5e5607a0, content=这杂志临床回顾性研究要吗<span class="quote">215245994_27814198 2018-10-18 16:18:00 发表:<br>刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的</span>, beContent=215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562132, encodeId=e1b356213248, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6332115095, createdName=215245994_27814198, createdTime=Thu Oct 18 16:18:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]
    2021-07-31 ms9000000745584421

    偏重的研究方向: 昆虫学 ; 遗传学
    经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=978599, encodeId=c9b29e8599e1, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:生物信息;遗传<br>经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd95538628, createdName=无名氏大神, createdTime=Thu Jul 01 12:28:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115163, encodeId=785521151634a, content=这个期刊要求提交WB、RT-PCR等实验的原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8798538309, createdName=ms8000001983091391, createdTime=Fri Feb 17 22:49:05 CST 2023, time=2023-02-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1004198, encodeId=eaa410041988e, content=偏重的研究方向: 昆虫学 ; 遗传学 <br>经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7d5455041, createdName=ms9000000745584421, createdTime=Sat Jul 31 11:05:31 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199422, encodeId=234d119942250, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:遗传育种;生信分析<br>经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Fri Mar 04 16:26:29 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199424, encodeId=0a23119942413, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=ae0510446253' target=_blank style='color:#2F92EE;'>#周舟#</a>我的到现在还没有审核通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=104462, encryptionId=ae0510446253, topicName=周舟)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Fri Mar 04 16:31:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097241, encodeId=94dd109e2414e, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097242, encodeId=5329109e24253, content=对于审稿人好的意见也要回复么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186528, encodeId=dc04118652824, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:林学<br>经验分享:非常好的一个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Thu Jan 20 18:20:59 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575607, encodeId=b8ee5e5607a0, content=这杂志临床回顾性研究要吗<span class="quote">215245994_27814198 2018-10-18 16:18:00 发表:<br>刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的</span>, beContent=215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562132, encodeId=e1b356213248, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6332115095, createdName=215245994_27814198, createdTime=Thu Oct 18 16:18:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]
    2022-03-04 Medsciding

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:遗传育种;生信分析
    经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=978599, encodeId=c9b29e8599e1, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:生物信息;遗传<br>经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd95538628, createdName=无名氏大神, createdTime=Thu Jul 01 12:28:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115163, encodeId=785521151634a, content=这个期刊要求提交WB、RT-PCR等实验的原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8798538309, createdName=ms8000001983091391, createdTime=Fri Feb 17 22:49:05 CST 2023, time=2023-02-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1004198, encodeId=eaa410041988e, content=偏重的研究方向: 昆虫学 ; 遗传学 <br>经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7d5455041, createdName=ms9000000745584421, createdTime=Sat Jul 31 11:05:31 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199422, encodeId=234d119942250, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:遗传育种;生信分析<br>经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Fri Mar 04 16:26:29 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199424, encodeId=0a23119942413, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=ae0510446253' target=_blank style='color:#2F92EE;'>#周舟#</a>我的到现在还没有审核通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=104462, encryptionId=ae0510446253, topicName=周舟)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Fri Mar 04 16:31:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097241, encodeId=94dd109e2414e, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097242, encodeId=5329109e24253, content=对于审稿人好的意见也要回复么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186528, encodeId=dc04118652824, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:林学<br>经验分享:非常好的一个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Thu Jan 20 18:20:59 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575607, encodeId=b8ee5e5607a0, content=这杂志临床回顾性研究要吗<span class="quote">215245994_27814198 2018-10-18 16:18:00 发表:<br>刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的</span>, beContent=215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562132, encodeId=e1b356213248, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6332115095, createdName=215245994_27814198, createdTime=Thu Oct 18 16:18:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]
    2022-03-04 IMzhouyu

    #期刊论坛##周舟#我的到现在还没有审核通过

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=978599, encodeId=c9b29e8599e1, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:生物信息;遗传<br>经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd95538628, createdName=无名氏大神, createdTime=Thu Jul 01 12:28:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115163, encodeId=785521151634a, content=这个期刊要求提交WB、RT-PCR等实验的原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8798538309, createdName=ms8000001983091391, createdTime=Fri Feb 17 22:49:05 CST 2023, time=2023-02-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1004198, encodeId=eaa410041988e, content=偏重的研究方向: 昆虫学 ; 遗传学 <br>经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7d5455041, createdName=ms9000000745584421, createdTime=Sat Jul 31 11:05:31 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199422, encodeId=234d119942250, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:遗传育种;生信分析<br>经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Fri Mar 04 16:26:29 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199424, encodeId=0a23119942413, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=ae0510446253' target=_blank style='color:#2F92EE;'>#周舟#</a>我的到现在还没有审核通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=104462, encryptionId=ae0510446253, topicName=周舟)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Fri Mar 04 16:31:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097241, encodeId=94dd109e2414e, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097242, encodeId=5329109e24253, content=对于审稿人好的意见也要回复么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186528, encodeId=dc04118652824, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:林学<br>经验分享:非常好的一个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Thu Jan 20 18:20:59 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575607, encodeId=b8ee5e5607a0, content=这杂志临床回顾性研究要吗<span class="quote">215245994_27814198 2018-10-18 16:18:00 发表:<br>刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的</span>, beContent=215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562132, encodeId=e1b356213248, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6332115095, createdName=215245994_27814198, createdTime=Thu Oct 18 16:18:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    评审和期刊编辑要求我补实验,就一定要补么,不补行不行?

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=978599, encodeId=c9b29e8599e1, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:生物信息;遗传<br>经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd95538628, createdName=无名氏大神, createdTime=Thu Jul 01 12:28:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115163, encodeId=785521151634a, content=这个期刊要求提交WB、RT-PCR等实验的原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8798538309, createdName=ms8000001983091391, createdTime=Fri Feb 17 22:49:05 CST 2023, time=2023-02-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1004198, encodeId=eaa410041988e, content=偏重的研究方向: 昆虫学 ; 遗传学 <br>经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7d5455041, createdName=ms9000000745584421, createdTime=Sat Jul 31 11:05:31 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199422, encodeId=234d119942250, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:遗传育种;生信分析<br>经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Fri Mar 04 16:26:29 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199424, encodeId=0a23119942413, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=ae0510446253' target=_blank style='color:#2F92EE;'>#周舟#</a>我的到现在还没有审核通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=104462, encryptionId=ae0510446253, topicName=周舟)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Fri Mar 04 16:31:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097241, encodeId=94dd109e2414e, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097242, encodeId=5329109e24253, content=对于审稿人好的意见也要回复么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186528, encodeId=dc04118652824, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:林学<br>经验分享:非常好的一个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Thu Jan 20 18:20:59 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575607, encodeId=b8ee5e5607a0, content=这杂志临床回顾性研究要吗<span class="quote">215245994_27814198 2018-10-18 16:18:00 发表:<br>刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的</span>, beContent=215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562132, encodeId=e1b356213248, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6332115095, createdName=215245994_27814198, createdTime=Thu Oct 18 16:18:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]
    2021-12-28 衣谷

    对于审稿人好的意见也要回复么?

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=978599, encodeId=c9b29e8599e1, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:生物信息;遗传<br>经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd95538628, createdName=无名氏大神, createdTime=Thu Jul 01 12:28:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115163, encodeId=785521151634a, content=这个期刊要求提交WB、RT-PCR等实验的原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8798538309, createdName=ms8000001983091391, createdTime=Fri Feb 17 22:49:05 CST 2023, time=2023-02-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1004198, encodeId=eaa410041988e, content=偏重的研究方向: 昆虫学 ; 遗传学 <br>经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7d5455041, createdName=ms9000000745584421, createdTime=Sat Jul 31 11:05:31 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199422, encodeId=234d119942250, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:遗传育种;生信分析<br>经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Fri Mar 04 16:26:29 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199424, encodeId=0a23119942413, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=ae0510446253' target=_blank style='color:#2F92EE;'>#周舟#</a>我的到现在还没有审核通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=104462, encryptionId=ae0510446253, topicName=周舟)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Fri Mar 04 16:31:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097241, encodeId=94dd109e2414e, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097242, encodeId=5329109e24253, content=对于审稿人好的意见也要回复么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186528, encodeId=dc04118652824, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:林学<br>经验分享:非常好的一个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Thu Jan 20 18:20:59 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575607, encodeId=b8ee5e5607a0, content=这杂志临床回顾性研究要吗<span class="quote">215245994_27814198 2018-10-18 16:18:00 发表:<br>刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的</span>, beContent=215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562132, encodeId=e1b356213248, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6332115095, createdName=215245994_27814198, createdTime=Thu Oct 18 16:18:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]
    2022-01-20 Medsciding

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:林学
    经验分享:非常好的一个期刊

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=978599, encodeId=c9b29e8599e1, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:生物信息;遗传<br>经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd95538628, createdName=无名氏大神, createdTime=Thu Jul 01 12:28:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115163, encodeId=785521151634a, content=这个期刊要求提交WB、RT-PCR等实验的原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8798538309, createdName=ms8000001983091391, createdTime=Fri Feb 17 22:49:05 CST 2023, time=2023-02-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1004198, encodeId=eaa410041988e, content=偏重的研究方向: 昆虫学 ; 遗传学 <br>经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7d5455041, createdName=ms9000000745584421, createdTime=Sat Jul 31 11:05:31 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199422, encodeId=234d119942250, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:遗传育种;生信分析<br>经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Fri Mar 04 16:26:29 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199424, encodeId=0a23119942413, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=ae0510446253' target=_blank style='color:#2F92EE;'>#周舟#</a>我的到现在还没有审核通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=104462, encryptionId=ae0510446253, topicName=周舟)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Fri Mar 04 16:31:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097241, encodeId=94dd109e2414e, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097242, encodeId=5329109e24253, content=对于审稿人好的意见也要回复么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186528, encodeId=dc04118652824, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:林学<br>经验分享:非常好的一个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Thu Jan 20 18:20:59 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575607, encodeId=b8ee5e5607a0, content=这杂志临床回顾性研究要吗<span class="quote">215245994_27814198 2018-10-18 16:18:00 发表:<br>刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的</span>, beContent=215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562132, encodeId=e1b356213248, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6332115095, createdName=215245994_27814198, createdTime=Thu Oct 18 16:18:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]
    2019-08-30 starry

    这杂志临床回顾性研究要吗215245994_27814198 2018-10-18 16:18:00 发表:
    刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的

    215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=978599, encodeId=c9b29e8599e1, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:生物信息;遗传<br>经验分享:权威遗传学杂志,审稿严格,中国人能投中的占比非常少,国际认可度非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd95538628, createdName=无名氏大神, createdTime=Thu Jul 01 12:28:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115163, encodeId=785521151634a, content=这个期刊要求提交WB、RT-PCR等实验的原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8798538309, createdName=ms8000001983091391, createdTime=Fri Feb 17 22:49:05 CST 2023, time=2023-02-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1004198, encodeId=eaa410041988e, content=偏重的研究方向: 昆虫学 ; 遗传学 <br>经验分享:请问plos genetics 一般with editor后多久决定送审还是直接拒稿?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7d5455041, createdName=ms9000000745584421, createdTime=Sat Jul 31 11:05:31 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199422, encodeId=234d119942250, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:遗传育种;生信分析<br>经验分享:国际认可度非常高的期刊,全球81本自然指数期刊之一,专家给的意见非常好,看的也很仔细,希望plos genetics越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Fri Mar 04 16:26:29 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199424, encodeId=0a23119942413, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=ae0510446253' target=_blank style='color:#2F92EE;'>#周舟#</a>我的到现在还没有审核通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=104462, encryptionId=ae0510446253, topicName=周舟)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Fri Mar 04 16:31:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097241, encodeId=94dd109e2414e, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097242, encodeId=5329109e24253, content=对于审稿人好的意见也要回复么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186528, encodeId=dc04118652824, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:林学<br>经验分享:非常好的一个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97ee5584396, createdName=Medsciding, createdTime=Thu Jan 20 18:20:59 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575607, encodeId=b8ee5e5607a0, content=这杂志临床回顾性研究要吗<span class="quote">215245994_27814198 2018-10-18 16:18:00 发表:<br>刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的</span>, beContent=215245994_27814198 2018-10-18 16:18:00 发表: 刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562132, encodeId=e1b356213248, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6332115095, createdName=215245994_27814198, createdTime=Thu Oct 18 16:18:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]
    2018-10-18 215245994_27814198

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:刚接收了一篇,本来投PLOS Biology的,被秒拒后建议转到PLOS Genetics,然后就转投这边,一审差不多一个月,两个审稿人,提的问题很专业,给了60天大修,补了个大实验,时间超了,跟编辑申请多了15天的修回时间,回复审稿人问题回复了12页,修回后10天就接收了。总结经验就是一定要认真按照审稿人的意见修改,哪怕要补很多实验,超时可以跟编辑申请延长,编辑也是很Nice的

    0

共54条页码: 1/6页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分